Latka logo

Funding

$0

Team

1

Founded

2015

Med-ly revenue, CEO Marg Patel, team size, customer count, churn, and more in 2022.

Medly Pharmacy is a digital pharmacy platform that offers free, same-day prescription delivery

Last updated

Med-ly Revenue

We do not have information about Med-ly's revenue yet.

Med-ly Valuation, Funding Rounds

Med-ly is a bootstrapped SaaS company, self-funded since its founding in 2015, with no outside investment to date.

Med-ly Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$120152015 cumulative: $0 • 2015 Founded: $02015 Founded: $0 valuationSource: GetLatka.com
YearRoundAmountValuation% Sold

Med-ly Employees & Team Size

Med-ly employs approximately 1 people as of 2026.

Med-ly has 1 total employees in different roles and functions.

Med-ly Team GrowthReported headcount over time0011112015201620172018201920200011Source: GetLatka.com
YearMilestone
2020Reached 1 employees (August 2020)

Founder / CEO

Marg Patel

Marg Patel is listed as Founder / CEO at Med-ly.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for Med-ly yet.

Frequently Asked Questions about Med-ly

What is Med-ly's revenue?

GetLatka has not confirmed a public revenue figure for Med-ly.

Who founded Med-ly?

Med-ly was founded by Marg Patel.

Who is the CEO of Med-ly?

The CEO of Med-ly is Marg Patel.

How much funding does Med-ly have?

Med-ly raised $0.

How many employees does Med-ly have?

Med-ly has 1 employees.

Where is Med-ly headquarters?

Med-ly is headquartered in Las Vegas, Nevada, United States.

Source Attribution

Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.

Company data last updated .

Med-ly Revenue, Valuation & Funding (2022)